搜尋結果 "#ProstateCancer"

動態

查看更多結果

Mary Grace N. Tamio shared news

在 December 27 2024 at 06:41 PM 已編輯

Night shift work and prostate cancer: a large cohort study from UK Biobank and Mendelian randomisation study

#prostatecancer #journals #articles

More info | ⬇️

Night shift work and prostate cancer: a large cohort study from UK Biobank and Mendelian randomisation study
STRENGTHS AND LIMITATIONS OF THIS STUDYThis represents the first study employing Mendelian randomisation to ascertain the ...
0 0 0 0 0 0 0

留言

Like

分享
Mary Grace N. Tamio shared news

在 November 13 2024 at 01:46 PM 已編輯

Compatibility of hypokalaemia caused by low-dose prednisolone plus abiraterone acetate therapy for metastatic castration-resistant prostate cancer

#hypokalaemia #prostatecancer #journals #articles

More info | ⬇️

Compatibility of hypokalaemia caused by low-dose prednisolone plus abiraterone acetate therapy for metastatic castration-resistant prostate cancer
This study aimed to investigate the relationship between low-dose prednisolone (PSL) and the incidence of hypokalaemia at ...
0 0 0 0 0 0 0

留言

Like

分享
Mary Grace N. Tamio shared news

在 September 04 2024 at 08:00 PM 已編輯

PSMA PET/CT imaging and its application to prostate cancer treatment

#CTimaging #prostatecancer #journals #articles

More info | ⬇️

PSMA PET/CT imaging and its application to prostate cancer treatment
Recognition of the importance of prostate-specific membrane antigen (PSMA) PET/CT in the diagnosis of prostate cancer has ...
0 0 0 0 0 0 0

留言

Like

分享
Mary Grace N. Tamio shared news

在 July 28 2024 at 07:29 PM 已編輯

Failure to progress: breast and prostate cancer cell lines in developing targeted therapies

#breastcancer #prostatecancer #journals #articles

More info | ⬇️

Failure to progress: breast and prostate cancer cell lines in developing targeted therapies
Developing anticancer drugs from preclinical to clinical takes approximately a decade in a cutting-edge biomedical lab and...
0 0 0 0 0 0 0

留言

Like

分享
Mary Grace N. Tamio shared news

在 February 07 2024 at 07:59 PM 已編輯

Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer

#prostatecancer #celladhesion #journals #articles

More info | ⬇️

Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
About 30% of Prostate cancer (PCa) patients progress to metastatic PCa that remains largely incurable. This evidence under...
0 0 0 0 0 0 0

留言

Like

分享

搜尋過濾器

搜尋結果 "#ProstateCancer"

動態